Acurx to Present Scientific Poster at ICDS Symposium
Acurx Pharmaceuticals said it will present a scientific poster at the Premier International C. difficile Symposium (ICDS) comparing in vitro kill kinetics of ibezapolstat versus vancomycin and fidaxomicin, including co-cultures.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.